Literature DB >> 19889147

Protein biomarker analysis of primary Peyronie's disease cells.

Ling X De Young1, Anthony J Bella, David B O'Gorman, Bing S Gan, Kok B Lim, Gerald B Brock.   

Abstract

INTRODUCTION: The molecular pathogenesis of Peyronie's Disease (PD) remains unclear more than 250 years after its initial description. Because of this, no test is currently available to accurately predict PD progression among those affected. AIM: To investigate the expression of wound healing and fibrosis-associated proteins in primary cell cultures of PD fibroblasts to determine whether altered protein expression patterns can be used as predictors of clinical course and natural history.
METHODS: Primary cell cultures derived from normal Tunica albuginea tissue and PD plaque tissue were examined by immuno-cytochemistry. Protein expression profiles were analyzed by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (SELDI-TOF-MS) and Western immunoblotting. MAIN OUTCOME MEASURES: Expression of wound healing and fibrosis-associated proteins and protein expression patterns were assessed.
RESULTS: Statistically significant increases in smooth muscle alpha-actin, beta-catenin, and Heat shock proteins (Hsp47) were identified in cells derived from PD relative to cells derived from normal Tunica albuginea tissue. Changes in TGFbeta-1 receptor and Fibronectin were also observed. In addition, altered expression of additional as yet unidentified proteins at 4.7, 8.9, 10.8, 16.8, and 76.8 kDa were detected by complementary SELDI-TOF-MS approaches.
CONCLUSIONS: Primary cells derived from PD plaques display up-regulated expression of several proteins that are established components of fibrosis and wound healing. In addition, changes in other, as yet unidentified proteins were measured. It will be of interest to conduct further studies to see whether these dysregulated protein peaks represent potential biological markers of disease progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889147     DOI: 10.1111/j.1743-6109.2009.01556.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

1.  Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix.

Authors:  Alan W Shindel; Guiting Lin; Hongxiu Ning; Lia Banie; Yun-Ching Huang; Gang Liu; Ching-Shwun Lin; Tom F Lue
Journal:  J Sex Med       Date:  2010-03-30       Impact factor: 3.802

2.  Reproducibility of SELDI Spectra Across Time and Laboratories.

Authors:  Lixia Diao; Charlotte H Clarke; Kevin R Coombes; Stanley R Hamilton; Jack Roth; Li Mao; Bogdan Czerniak; Keith A Baggerly; Jeffrey S Morris; Eric T Fung; Robert C Bast
Journal:  Cancer Inform       Date:  2011-03-14

3.  ABO Blood Type and Risk of Peyronie's Disease in Japanese Males.

Authors:  Yozo Mitsui; Hideyuki Kobayashi; Fumito Yamabe; Koichi Nakajima; Koichi Nagao
Journal:  World J Mens Health       Date:  2022-01-01       Impact factor: 6.494

4.  Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.

Authors:  M Alizadeh; F Karimi; M R Fallah
Journal:  Glob J Health Sci       Date:  2014-09-18

5.  Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.

Authors:  Martin K Gelbard; Joel Rosenbloom
Journal:  Endocrinol Diabetes Metab       Date:  2020-10-31

6.  The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease.

Authors:  Carla Loreto; Giampiero La Rocca; Rita Anzalone; Rosario Caltabiano; Giuseppe Vespasiani; Sergio Castorina; David J Ralph; Selim Cellek; Giuseppe Musumeci; Salvatore Giunta; Rados Djinovic; Dragoslav Basic; Salvatore Sansalone
Journal:  Biomed Res Int       Date:  2014-08-13       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.